FK 506 for vascular permeability factor production in minimal change nephrotic syndrome.
Maruyama
K
K
Tomizawa
S
S
Seki
Y
Y
Arai
H
H
Ogawa
T
T
Kuroume
T
T
D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000494:pharmacology; D016228:Endothelial Growth Factors / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008222:Lymphokines / Q000096:biosynthesis*; D008297:Male; D009402:Nephrosis, Lipoid / Q000188:drug therapy* / Q000378:metabolism; D013601:T-Lymphocytes / Q000187:drug effects / Q000378:metabolism; D016559:Tacrolimus / Q000008:administration & dosage / Q000494:pharmacology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D016572:Cyclosporine; D016559:Tacrolimus